NIH-funded research R01 grant

Improving care for thyroid cancer survivors by assessing their risk of recurrence

Official title: Risk-stratified care for thyroid cancer survivors

Funded at University of Michigan at Ann Arbor · NIH-11075898 · Data updated 2026-11-12

This study is looking to improve the follow-up care for people who have survived thyroid cancer by finding a better way to understand their chances of the cancer coming back, so they can get the right level of care without unnecessary stress.

More Cancer Survivors research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startApril 16, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$656,421
NIH project number5R01CA281976-02
Project IDNIH-11075898 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been diagnosed with thyroid cancer and are currently in the survivorship phase.

Less likely to help

Patients who have not been diagnosed with thyroid cancer or those who are currently undergoing active treatment may not benefit from this research.

What this research studies

This research aims to enhance the care of thyroid cancer survivors by developing a method to better assess their risk of cancer recurrence. By collaborating with various cancer registries and utilizing a comprehensive data collection strategy, the study will gather information from pathology reports, patient reports, and physician records. The goal is to identify which survivors are at higher or lower risk for recurrence and to tailor their follow-up care accordingly, potentially reducing unnecessary surveillance and associated anxiety.

Why it matters

Potential benefit: If successful, this research could lead to more personalized and effective follow-up care for thyroid cancer survivors, reducing unnecessary tests and anxiety.

How similar studies have gone: Previous research has shown success in risk stratification approaches for other cancer types, suggesting that this methodology could be effective for thyroid cancer as well.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Haymart, Megan Rist — University of Michigan at Ann Arbor
  • Study coordinator: Haymart, Megan Rist

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.